NCT04969120View on ClinicalTrials.gov

Metoclopramide and the Length of First Stage of Labor , a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions
Labour Duration and Metoclopramide
Interventions
DRUG

Metoclopramide 10mg

this group receive 10mg intravenous metoclopramide slowly over 2 minutes the medication will be repeated every 2 hours for a maximum three doses

DRUG

Placebo (0.9 sodium chloride)

this group receive 10mg intravenous placebo(0.9 sodium chloride) slowly over 2 minutes the medication will be repeated every 2 hours for a maximum three doses

Trial Locations (1)

11562

Obstetrics and gynecology department at kasralainy hospital, Cairo

All Listed Sponsors
lead

Cairo University

OTHER